VCA
IRMD icon

Verdence Capital Advisors’s iRadimed IRMD Stock Holding History

Verdence Capital Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,611
Closed -$636K – 680
2026
Q1 		$636K Buy
+6,611
New +$661K 0.04% 380

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Verdence Capital Advisors's IRMD Position: Q2 2026 in Review

Verdence Capital Advisors sold out of iRadimed (IRMD) in Q2 2026, closing a stake of 6,611 shares — an estimated $636K sold.

Verdence Capital Advisors first reported a position in IRMD in Q1 2026 and held it in 1 quarter. The position peaked at $636K in Q1 2026. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Verdence Capital Advisors reported no remaining iRadimed position as of Q2 2026 after selling out during the quarter.
  • Verdence Capital Advisors sold 6,611 iRadimed shares in Q2 2026, an estimated $636K.
  • Verdence Capital Advisors first reported a position in iRadimed in Q1 2026 and held it in 1 quarter.
  • Verdence Capital Advisors's iRadimed position peaked at $636K in Q1 2026.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Verdence Capital Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.